27 studies found for:    ATTRACT
Show Display Options
Rank Status Study
1 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
2 Active, not recruiting CD5024 1% Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Condition: Papulopustular Rosacea
Interventions: Drug: CD5024;   Drug: Metronidazole 0.75% cream
3 Terminated The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)
Condition: Arthritis, Rheumatoid
Intervention: Other: Retrospective Chart Review and Data collection
4 Recruiting Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System)
Conditions: Deafness;   Hearing Loss;   Hearing Loss, Conductive
Intervention: Device: Baha Attract System
5 Terminated A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: ASA404;   Drug: Placebo;   Drug: docetaxel
6 Active, not recruiting Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Neurotoxicity;   Pain;   Peripheral Neuropathy;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: ketamine/amitriptyline NP-H cream;   Other: placebo
7 Completed A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
Condition: Migraine
Intervention: Drug: Frovatriptan
8 Completed Intra-uterine Injection of Human Chorionic Gonadotrophin (hCG) Before Embryo Transfer
Condition: Infertility
Intervention: Drug: human chorionic gonadotrophin
9 Completed A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)
Condition: Arthritis, Rheumatoid
Interventions: Other: Placebo;   Drug: MTX;   Biological: Infliximab
10 Not yet recruiting Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
Conditions: Transitional Cell Carcinoma;   Bladder Cancer;   Carcinoma in Situ;   Carcinoma in Situ Concurrent With Papillary Tumors
Interventions: Biological: CG0070 adenovirus vector;   Other: Control Arm: Quadruple Choice
11 Recruiting Phase 2A Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
Conditions: Metastatic Pancreatic Cancer;   Metastatic Colorectal Cancer
Intervention: Drug: NPC-1C/NEO-102
12 Not yet recruiting Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients
Condition: Influenza
Intervention:
13 Completed Prediction of Acute Rejection in Renal Transplant
Condition: Kidney Transplant
Intervention:
14 Unknown  "Step by Step": A Feasibility Study of the Promotion of Lunchtime Walking to Increase Physical Activity and Improve Mental Well-being in Sedentary Employees
Conditions: Exercise;   Sedentary
Interventions: Other: 16-week lunchtime walking intervention;   Other: delayed treatment
15 Unknown  Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
Conditions: Chronic Obstructive Airway Disease;   Healthy Volunteers
Intervention: Procedure: Up to 100ml blood will be taken by venupuncture.
16 Completed NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
Condition: Malignant Melanoma
Interventions: Biological: NY-ESO-1 protein;   Drug: Imiquimod
17 Active, not recruiting Queen's University Investigation of Calcification in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: Bisphosphonate;   Drug: Placebo
18 Active, not recruiting Benefits and Costs of Integrating Sexual-Reproductive Health and HIV Services in Kenya and Swaziland
Conditions: Pregnancy;   HIV
Intervention: Procedure: Integrated FP/PNC service delivery
19 Recruiting Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral ß-glucan for High-Risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH
20 Completed Research in Skin Inflammation
Condition: Psoriasis
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years